search
Back to results

Reduction of Postoperative Wound Infections by Antiseptica? (RECIPE)

Primary Purpose

Surgical Site Infection

Status
Completed
Phase
Phase 3
Locations
Germany
Study Type
Interventional
Intervention
Polihexanide; Serasept
NaCl; saline
Sponsored by
Johannes Lauscher
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Surgical Site Infection

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: - planned laparotomy for visceral surgery

Exclusion Criteria:

  • Age under 18 years
  • allergy against polihexanid
  • laparoscopic surgery
  • emergency surgery
  • lack of understanding of the trial

Sites / Locations

  • Charité Campus Benjamin Franklin

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Subcutaneous irrigation with 0.04% polyhexanide solution

Subcutaneous irrigation with NaCl (saline)

Arm Description

Intervention: after closure of abdominal fascia, an intraoperative irrigation of the subcutaneous tissue with 250 ml antiseptic solution (0.04% polyhexanide) will be done once for ten minutes. No subcutaneous suture. Closure of skin with either staples, interrupted sutures or running suture.

Intervention: after closure of fascia, an intraoperative irrigation of the subcutaneous tissue with 250 ml NaCl (saline) will be done once for one minute. No subcutaneous suture. Closure of skin with either staples, interrupted sutures or running suture.

Outcomes

Primary Outcome Measures

surgical site infection
Surgical site infection according to CDC definition.

Secondary Outcome Measures

Full Information

First Posted
April 25, 2018
Last Updated
August 12, 2019
Sponsor
Johannes Lauscher
search

1. Study Identification

Unique Protocol Identification Number
NCT04055233
Brief Title
Reduction of Postoperative Wound Infections by Antiseptica?
Acronym
RECIPE
Official Title
Reduction of Postoperative Wound Infections by Antiseptica?
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
February 1, 2015 (Actual)
Primary Completion Date
September 10, 2018 (Actual)
Study Completion Date
October 20, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Johannes Lauscher

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Wound infections are a frequent complication in abdominal surgery. The investigators hypothesize that the antiseptic solution 0.04 % polyhexanide (serasept) may reduce occurrence of postoperative wound infections compared to NaCL (saline) solution in a prospective randomized setting.
Detailed Description
Invstigator initiated monocenter randomized controlled trial. Intraoperative irrigation of subcutaneous tissue with NaCl (saline) solution or antiseptic solution 0.04 % polyhexanide (Serasept) in elective abdominal surgery. Primary endpoint: SSI 30 days postoperatively according to CDC criteria.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Site Infection

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Two arm prospective randomized single center interventional trial. 1:1 randomization into experimental arm (irrigation with polyhexanide) and control arm (irrigation with saline).
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
456 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Subcutaneous irrigation with 0.04% polyhexanide solution
Arm Type
Experimental
Arm Description
Intervention: after closure of abdominal fascia, an intraoperative irrigation of the subcutaneous tissue with 250 ml antiseptic solution (0.04% polyhexanide) will be done once for ten minutes. No subcutaneous suture. Closure of skin with either staples, interrupted sutures or running suture.
Arm Title
Subcutaneous irrigation with NaCl (saline)
Arm Type
Active Comparator
Arm Description
Intervention: after closure of fascia, an intraoperative irrigation of the subcutaneous tissue with 250 ml NaCl (saline) will be done once for one minute. No subcutaneous suture. Closure of skin with either staples, interrupted sutures or running suture.
Intervention Type
Drug
Intervention Name(s)
Polihexanide; Serasept
Other Intervention Name(s)
Polihexanide (0.04% antiseptic solution)
Intervention Description
Experimental arm: irrigation of subcutaneous tissue after fascia closure with polihexanide (ten minutes). A single dose of perioperative antibiotics (cefuroxim alone or cefuroxim and metrodidazole in bowel surgeries) was given 30 minutes before skin incision. Hair removal was done with electronic clippers and preoperative skin antisepsis was performed with propanol and povidone-iodine. Before closure of fascia, instruments and gloves were changed. No subcutaneous suture was used. Skin was closed either with skin staples, continuous intracutaneous suture or interrupted suture. All surgeries were done according to the Standard Operating Procedures of the Department for General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin.
Intervention Type
Drug
Intervention Name(s)
NaCl; saline
Other Intervention Name(s)
NaCl (saline)
Intervention Description
Control arm: irrigation of subcutaneous tissue after fascia closure with NaCl (one minute) A single dose of perioperative antibiotics (cefuroxim alone or cefuroxim and metrodidazole in bowel surgeries) was given 30 minutes before skin incision. Hair removal was done with electronic clippers and preoperative skin antisepsis was performed with propanol and povidone-iodine. All surgeries were done according to the Standard Operating Procedures of the Department for General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin. Before closure of fascia, instruments and gloves were changed. No subcutaneous suture was used. Skin was closed either with skin staples, continuous intracutaneous suture or interrupted suture. All surgeries were done according to the Standard Operating Procedures of the Department for General, Visceral and Vascular Surgery, Charité Campus Benjamin Franklin.
Primary Outcome Measure Information:
Title
surgical site infection
Description
Surgical site infection according to CDC definition.
Time Frame
30 days postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - planned laparotomy for visceral surgery Exclusion Criteria: Age under 18 years allergy against polihexanid laparoscopic surgery emergency surgery lack of understanding of the trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Johannes C Lauscher, MD
Organizational Affiliation
Charité-University Medicine (Berlin, Germany)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Charité Campus Benjamin Franklin
City
Berlin-Steglitz
State/Province
Berlin
ZIP/Postal Code
12200
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35263172
Citation
Strobel RM, Leistner R, Leonhardt M, Neumann K, Eschlbock SM, Lee LDG, Seifarth C, Schineis CHW, Kamphues C, Weixler B, Beyer K, Lauscher JC. Is There an Association between Intra-Operative Detection of Pathogens in Subcutaneous Tissue and Surgical Site Infections? Results from a Prospective Study. Surg Infect (Larchmt). 2022 May;23(4):372-379. doi: 10.1089/sur.2021.154. Epub 2022 Mar 9.
Results Reference
derived
PubMed Identifier
31599810
Citation
Strobel RM, Leonhardt M, Krochmann A, Neumann K, Speichinger F, Hartmann L, Lee LD, Beyer K, Daum S, Kreis ME, Lauscher JC. Reduction of Postoperative Wound Infections by Antiseptica (RECIPE)?: A Randomized Controlled Trial. Ann Surg. 2020 Jul;272(1):55-64. doi: 10.1097/SLA.0000000000003645.
Results Reference
derived

Learn more about this trial

Reduction of Postoperative Wound Infections by Antiseptica?

We'll reach out to this number within 24 hrs